Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Dec;88(12):1801-6.
doi: 10.2105/ajph.88.12.1801.

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996

D C Des Jarlais  1 , T Perlis, S R Friedman, S Deren, T Chapman, J L Sotheran, S Tortu, M Beardsley, D Paone, L V Torian, S T Beatrice, E DeBernardo, E Monterroso, M Marmor
Affiliations

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996

D C Des Jarlais et al. Am J Public Health. 1998 Dec.

Abstract

Objectives: This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City.

Methods: We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research storefronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11,334 serum samples were tested.

Results: From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53% to 36% in the detoxification program, from 45% to 29% in the methadone program, from 44% to 22% at the Lower East Side storefront, from 48% to 21% at the Harlem storefront, and from 30% to 21% in the sexually transmitted disease clinics (all P < .002 by chi 2 tests for trend).

Conclusions: The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of HIV-seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.

PubMed Disclaimer

References

    1. Lancet. 1996 Oct 12;348(9033):987-91 - PubMed
    1. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):514-8 - PubMed
    1. Ann Intern Med. 1985 Nov;103(5):755-9 - PubMed
    1. Int J Addict. 1987 Mar;22(3):201-19 - PubMed
    1. AIDS. 1987 Dec;1(4):247-54 - PubMed

Publication types

LinkOut - more resources